Octreotide microspheres to prevent pancreatic fistula after pancreas surgery
Part of Digestive system clinical trials.
This study tests if octreotide microspheres (a slow-release drug) can prevent pancreatic fistula—a common complication after surgery to remove the tail of the pancreas. The goal is to help patients heal with fewer complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are scheduled for a surgery to remove the tail of your pancreas (called distal pancreatectomy).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study; you agree to use reliable birth control.
- You do not have serious liver disease (like cirrhosis), uncontrolled infections, or bleeding problems.
- You have not used octreotide or similar long-acting drugs before, and you are not allergic to them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a short course of radiation before surgery can lower the risk of a pancreatic leak (a common complication). It is for people who are overweight, older than 45, and have a small pancreatic duct.
This study tests whether placing an external pancreatic duct stent after pancreaticoduodenectomy can lower the risk of pancreatic leak (pancreatic fistula). If you had this surgery with a specific connection technique, you may be able to help find a safer way to prevent complications.
This trial looks at factors that can predict a serious complication called a pancreatic fistula (a leak from the pancreas) after a Whipple procedure. The goal is to help doctors better understand and manage this risk.
This study looks at people having planned Whipple surgery (a type of pancreas surgery) to understand why some develop a leak called a pancreatic fistula. Researchers will study your blood and immune system to find ways to predict and prevent this complication.
This trial tests if placing a small tube (stent) in the pancreas during Whipple surgery helps prevent leaks. It is for patients whose pancreas is found to be soft during surgery.
This Phase 1/2 study tests whether adding an islet (insulin-producing cell) transplant at the time of pancreatic-region surgery is safe and helps prevent a serious surgical complication called a postoperative fistula. It is for people whose surgery is considered high risk for developing that complication.
Hear when a new Pancreatic Fistula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.